학술논문

Phase III randomized trial comparing systemic versus intra-arterial oxaliplatin, combined with LV5FU2+/- irinotecan and a targeted therapy, in the first-line treatment of metastatic colorectal cancer restricted to the liver (OSCAR): PRODIGE 49

Document Type
Journal
Source
DIGESTIVE AND LIVER DISEASE; MAR 2022, 54 3, p324-p330, 7p.
Subject
Language
English
ISSN
18783562